150 related articles for article (PubMed ID: 32365398)
1. Effects of Short Term Metformin Treatment on Brown Adipose Tissue Activity and Plasma Irisin Levels in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial.
Oliveira FR; Mamede M; Bizzi MF; Rocha ALL; Ferreira CN; Gomes KB; Cândido AL; Reis FM
Horm Metab Res; 2020 Oct; 52(10):718-723. PubMed ID: 32365398
[TBL] [Abstract][Full Text] [Related]
2. Brown adipose tissue activity is reduced in women with polycystic ovary syndrome.
Oliveira FR; Mamede M; Bizzi MF; Rocha ALL; Ferreira CN; Gomes KB; Cândido AL; Reis FM
Eur J Endocrinol; 2019 Nov; 181(5):473-480. PubMed ID: 31491743
[TBL] [Abstract][Full Text] [Related]
3. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
4. Effect of Metformin Treatment on Insulin Resistance Markers, and Circulating Irisin in Women with Polycystic Ovarian Syndrome (PCOS).
Masaeli A; Nayeri H; Mirzaee M
Horm Metab Res; 2019 Sep; 51(9):575-579. PubMed ID: 31121610
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
6. Irisin reduces the abnormal reproductive and metabolic phenotypes of PCOS by regulating the activity of brown adipose tissue in mice†.
Zheng Y; He J; Yang D; Yuan M; Liu S; Dai F; Jia Y; Cheng Y
Biol Reprod; 2022 Oct; 107(4):1046-1058. PubMed ID: 35713297
[TBL] [Abstract][Full Text] [Related]
7. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
[TBL] [Abstract][Full Text] [Related]
8. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
9. The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial.
Lord J; Thomas R; Fox B; Acharya U; Wilkin T
BJOG; 2006 Jul; 113(7):817-24. PubMed ID: 16827766
[TBL] [Abstract][Full Text] [Related]
10. Circulating zinc-α2-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment.
Zheng S; Liu E; Zhang Y; Long T; Liu X; Gong Y; Mai T; Shen H; Chen H; Lin R; Zheng Y; Xie Y; Wang F
Endocr J; 2019 Jun; 66(6):555-562. PubMed ID: 30918134
[TBL] [Abstract][Full Text] [Related]
11. Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome.
Chang CL; Huang SY; Soong YK; Cheng PJ; Wang CJ; Liang IT
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2539-48. PubMed ID: 25029417
[TBL] [Abstract][Full Text] [Related]
12. Impact of Metformin on IVF Outcomes in Overweight and Obese Women With Polycystic Ovary Syndrome: A Randomized Double-Blind Controlled Trial.
Abdalmageed OS; Farghaly TA; Abdelaleem AA; Abdelmagied AE; Ali MK; Abbas AM
Reprod Sci; 2019 Oct; 26(10):1336-1342. PubMed ID: 29576001
[TBL] [Abstract][Full Text] [Related]
13. Impact of metformin on anti-Müllerian hormone in women with polycystic ovary syndrome: a secondary analysis of a randomized controlled trial.
Madsen HN; Lauszus FF; Trolle B; Ingerslev HJ; Tørring N
Acta Obstet Gynecol Scand; 2015 May; 94(5):547-51. PubMed ID: 25736975
[TBL] [Abstract][Full Text] [Related]
14. Treatment with Metformin and Combination of Metformin Plus Pioglitazone on Serum Levels of IL-6 and IL-8 in Polycystic Ovary Syndrome: A Randomized Clinical Trial.
Ali DE; Shah M; Ali A; Malik MO; Rehman F; Badshah H; Ehtesham E; Vitale SG
Horm Metab Res; 2019 Nov; 51(11):714-722. PubMed ID: 31683341
[TBL] [Abstract][Full Text] [Related]
15. Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Jamilian H; Jamilian M; Foroozanfard F; Afshar Ebrahimi F; Bahmani F; Asemi Z
J Psychosom Obstet Gynaecol; 2018 Dec; 39(4):307-314. PubMed ID: 28980870
[TBL] [Abstract][Full Text] [Related]
16. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans.
Choi HY; Kim S; Park JW; Lee NS; Hwang SY; Huh JY; Hong HC; Yoo HJ; Baik SH; Youn BS; Mantzoros CS; Choi KM
J Clin Endocrinol Metab; 2014 Aug; 99(8):2778-85. PubMed ID: 24780049
[TBL] [Abstract][Full Text] [Related]
17. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
Zhang L; Fang X; Li L; Liu R; Zhang C; Liu H; Tan M; Yang G
J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
[TBL] [Abstract][Full Text] [Related]
18. Maternal and fetal insulin levels at birth in women with polycystic ovary syndrome: data from a randomized controlled study on metformin.
Helseth R; Vanky E; Stridsklev S; Vogt C; Carlsen SM
Eur J Endocrinol; 2014 May; 170(5):769-75. PubMed ID: 24595965
[TBL] [Abstract][Full Text] [Related]
19. Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
García-Beltran C; Cereijo R; Quesada-López T; Malpique R; López-Bermejo A; de Zegher F; Ibáñez L; Villarroya F
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32107266
[TBL] [Abstract][Full Text] [Related]
20. Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin.
Fruzzetti F; Ghiadoni L; Virdis A; De Negri F; Perini D; Bucci F; Giannarelli C; Gadducci A; Taddei S
J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):489-495. PubMed ID: 27018756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
